Cue Financial Group Has Decreased Cvs Health (CVS) Position By $338,286; Aehr Test Systems (AEHR) Sentiment Is 1.67

May 19, 2017 - By Clifton Ray

Aehr Test Systems is engaged in the designing, manufacturing and marketing of advanced test and burn-in products to the semiconductor manufacturing industry. The company has market cap of $62.91 million. The Firm makes and markets full wafer contact test systems, test during burn-in systems, test fixtures, die carriers and related accessories. It currently has negative earnings. The Company’s principal products are the Advanced Burn-In and Test System , the FOX full wafer contact parallel test and burn-in systems, WaferPak full wafer contactor, the DiePak carrier and test fixtures.

Cue Financial Group Inc decreased Cvs Health Corp (CVS) stake by 62.4% reported in 2016Q4 SEC filing. Cue Financial Group Inc sold 4,337 shares as Cvs Health Corp (CVS)’s stock 0.00%. The Cue Financial Group Inc holds 2,613 shares with $206,000 value, down from 6,950 last quarter. Cvs Health Corp now has $75.31 billion valuation. The stock increased 0.38% or $0.29 during the last trading session, reaching $76.62. About shares traded. CVS Health Corp (NYSE:CVS) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Analysts await Aehr Test Systems (NASDAQ:AEHR) to report earnings on July, 25. They expect $-0.04 earnings per share, up 82.61% or $0.19 from last year’s $-0.23 per share. After $-0.16 actual earnings per share reported by Aehr Test Systems for the previous quarter, Wall Street now forecasts -75.00% EPS growth.

The stock increased 1.22% or $0.05 on May 18, reaching $4.15. About shares traded. Aehr Test Systems (NASDAQ:AEHR) has risen 6.00% since April 19, 2017 and is uptrending. It has by 0.00% the S&P500.

Awm Investment Company Inc. holds 0.5% of its portfolio in Aehr Test Systems for 1.05 million shares. Minerva Advisors Llc owns 50,613 shares or 0.07% of their US portfolio. Moreover, Blackrock Fund Advisors has 0% invested in the company for 4,011 shares. The Germany-based Deutsche Bank Ag has invested 0% in the stock. Geode Capital Management Llc, a Massachusetts-based fund reported 82,292 shares.

Since January 1, 0001, it had 0 buys, and 9 selling transactions for $1.05 million activity.

Since February 1, 2017, it had 0 insider buys, and 6 insider sales for $22.09 million activity. 23,849 shares were sold by Brennan Troyen A, worth $1.88 million. Shares for $479,908 were sold by Boratto Eva C on Friday, March 17. 14,104 CVS Health Corp (NYSE:CVS) shares with value of $1.13M were sold by Sussman Andrew. $4.90M worth of CVS Health Corp (NYSE:CVS) was sold by Roberts Jonathan C on Thursday, February 16. Shares for $5.99M were sold by MERLO LARRY J. Denton David M sold $7.71M worth of stock or 95,618 shares.

Cue Financial Group Inc increased First Tr Value Line Divid In (FVD) stake by 14,546 shares to 35,430 valued at $993,000 in 2016Q4. It also upped Vanguard World Fds (VPU) stake by 2,950 shares and now owns 4,993 shares. Smith A O (NYSE:AOS) was raised too.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on August, 1. They expect $1.31 EPS, down 0.76% or $0.01 from last year’s $1.32 per share. CVS’s profit will be $1.29 billion for 14.62 P/E if the $1.31 EPS becomes a reality. After $1.17 actual EPS reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 11.97% EPS growth.